Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial

Open access
Zhang, Jian, Lv, Samei, Liu, Xiaojing, Song, Bin, Shi, Liping · 2018 · Gut and Liver

Abstract

Background/Aims: Stem cell therapy has been applied to treat a variety of autoimmune diseases, including Crohn's disease (CD), but few studies have examined the use of umbilical cord mesenchymal stem cells (UC-MSCs).This trial sought to investigate the efficacy and safety of UC-MSCs for the treatment of CD.Methods: Eighty-two patients who had been diagnosed with CD and had received steroid maintenance therapy for more than 6 months were included in this study.Forty-one patients were randomly selected to receive a total of four peripheral intravenous infusions of 1×10 6 UC-MSCs/kg, with one infusion per week.Patients were followed up for 12 months.The Crohn's disease activity index (CDAI), Harvey-Bradshaw index (HBI), and corticosteroid dosage were assessed.Results: Twelve months after treatment, the CDAI, HBI, and corticosteroid dosage had decreased by 62.5±23.2,3.4±1.2,and 4.2±0.84mg/day, respectively, in the UC-MSC group and by 23.6±12.4,1.2±0.58,and 1.2±0.35mg/day, respectively, in the control group (p<0.01,p<0.05, and p<0.05 for UC-MSC vs control, respectively).Four patients developed a fever after cell infusion.No serious adverse events were observed.Conclusions: UC-MSCs were effective in the treatment of CD and produced mild side effects.(Gut Liver 2018;12:73-78)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5009/gnl17035

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 170

Metadata

Authors
Zhang, J., Lv, S., Liu, X., Song, B., & Shi, L.
Venue
Gut and Liver
Published
2018-01-15
Volume
12
Issue
1
Pages
73-78
ISSN
  • 1976-2283 (ISSN-L)
  • 2005-1212
OpenAlex
W2751308524
Cited by
170
References
3
FWCI
6.87
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.